Christopher Heery
Director Técnico/Científico/I+D en ARCELLX, INC. .
Fortuna: 482 456 $ al 31/05/2024
Perfil
Christopher R.
Heery is currently the Chief Medical Officer at Arcellx, Inc. Prior to this, he was the Chief Medical Officer at Precision BioSciences, Inc. from 2019 to 2021.
He also held the position of Chief Medical Officer at Bavarian Nordic A and was the Head-Clinical Trials at the National Cancer Institute.
Heery received his undergraduate degree from Duke University and his doctorate from Brody School of Medicine in 2006.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARCELLX, INC.
0.02% | 12/06/2024 | 9 278 ( 0.02% ) | 482 456 $ | 31/05/2024 |
Cargos activos de Christopher Heery
| Empresas | Cargo | Inicio |
|---|---|---|
| ARCELLX, INC. | Director Técnico/Científico/I+D | 01/04/2021 |
Antiguos cargos conocidos de Christopher Heery.
| Empresas | Cargo | Fin |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 23/04/2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| BAVARIAN NORDIC A/S | Director Técnico/Científico/I+D | - |
Formación de Christopher Heery.
| Duke University | Undergraduate Degree |
| Brody School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| ARCELLX, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Bolsa de valores
- Insiders
- Christopher Heery
